We're thrilled to announce Doris Molina-Henry's participation in the upcoming American College of Neuropsychopharmacology (ACNP) Annual Meeting. This year's meeting is on December 8-11, 2024 in Phoenix, Arizona. The ACNP meeting is a premier forum for researchers and clinicians to share cutting-edge knowledge on brain health and pharmacotherapeutics.
Molina-Henry, a leading researcher at ATRI, will be part of a group study session titled "Will Recent Therapeutic Advances Change the Clinical Course of Alzheimer's Disease?" Scheduled for Tuesday, December 10th, the discussion will delve into the exciting treatment possibilities now available for Alzheimer's Disease and their implications. Molina-Henry will explore the biomarker eligibility differences across racial and ethnic populations.
This interactive session is a must-attend for anyone interested in the latest developments in Alzheimer's research. Molina-Henry will be joined by a distinguished panel of experts, fostering a dynamic discussion and offering valuable insights into the future of Alzheimer's care.
Registration for the ACNP Annual Meeting is now open. All researchers, clinicians, and healthcare professionals with an interest in Alzheimer's Disease should consider attending. We also encourage you to follow Doris Molina-Henry's work and sign up for our newsletter below.
